Benjamin M Scirica
Overview
Explore the profile of Benjamin M Scirica including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
244
Citations
8523
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Aggarwal R, Bhatt D, Szarek M, Cannon C, Leiter L, Inzucchi S, et al.
Lancet Diabetes Endocrinol
. 2025 Feb;
PMID: 39961315
Background: Sodium-glucose co-transporter (SGLT)-2 inhibitors have shown consistent benefit in improving heart failure-related outcomes but not ischaemic cardiovascular events such as myocardial infarction or stroke. We assessed if the dual...
2.
Unlu O, Varugheese M, Shin J, Subramaniam S, Stein D, St Laurent J, et al.
JAMA
. 2025 Feb;
PMID: 39960745
No abstract available.
3.
Hassan S, Blood A, Zelle D, Kumar S, Wagholikar K, Gabovitch D, et al.
Hypertension
. 2025 Jan;
PMID: 39886769
Background: Hypertension is a major cardiovascular risk factor, yet traditional care often results in suboptimal blood pressure (BP) control at the population level. We implemented a remote hypertension management program...
4.
Unlu O, Cannon C, Lee S, Gabovitch D, Zelle D, Chin N, et al.
Am J Hypertens
. 2025 Jan;
PMID: 39789184
Background: Remote hypertension management programs have emerged as potential solutions to improve poor rates of blood pressure (BP) control. The Continual Versus Occasional Blood Pressure (COOL-BP) Study investigated the feasibility...
5.
Snider S, Molyneaux B, Murthy A, Rademaker Q, Rajwani H, Scirica B, et al.
Anesthesiology
. 2025 Jan;
PMID: 39786948
Introduction: Accurate prognostication in comatose survivors of cardiac arrest is a challenging and high-stakes endeavor. We sought to determine whether internal EEG subparameters extracted by the Bispectral Index (BIS) monitor,...
6.
Blood A, Chang L, Colling C, Stern G, Gabovitch D, Zelle D, et al.
Am Heart J
. 2025 Jan;
282:114-124.
PMID: 39778759
Background: The prevalence, chronicity and clinical impact of type 2 diabetes (T2D) defines this disease state as a critical determinant in morbidity and mortality, as encountered by individuals, health care...
7.
Ostrominski J, Wagholikar K, Olsson K, Unlu O, Zelle D, Kumar S, et al.
Obesity (Silver Spring)
. 2024 Dec;
33(2):365-384.
PMID: 39696750
Objective: The objective of this study was to describe the prevalence of obesity, obesity-related conditions (ORCs), and antiobesity medication (AOM) eligibility and prescribing practice among eligible patients in a large...
8.
Hassan S, Chang L, Gabovitch D, Chasse J, Stern G, Colling C, et al.
Am Heart J
. 2024 Sep;
278:181-185.
PMID: 39303834
We describe the strategies used to identify and enroll participants in a remote health management program aimed at optimizing diabetes care in patients at high cardiovascular and kidney risk. Using...
9.
Scirica B, Lincoff A, Lingvay I, Bogdanski P, Buscemi S, Colhoun H, et al.
J Am Coll Cardiol
. 2024 Sep;
84(17):1632-1642.
PMID: 39217559
Background: Patients with overweight and obesity are at increased risk of death from multiple causes, including cardiovascular (CV) death, with few therapies proven to reduce the risk. Objectives: This study...
10.
Deanfield J, Verma S, Scirica B, Kahn S, Emerson S, Ryan D, et al.
Lancet
. 2024 Aug;
404(10454):773-786.
PMID: 39181597
Background: Semaglutide, a GLP-1 receptor agonist, reduces the risk of major adverse cardiovascular events (MACE) in people with overweight or obesity, but the effects of this drug on outcomes in...